Table of Contents Table of Contents
Previous Page  5 / 42 Next Page
Information
Show Menu
Previous Page 5 / 42 Next Page
Page Background

Leighl– ASCO 2017

PD-L1 >50%--58%

N-27

3-y OS phase I KEYNOTE 001 Trial